Projects

Mgr. Lucia Kindernay, PhD.

International

Finished
  • Effect of pathological states on cardiac resistance against myocardial ischemia: study of molecular mechanisms and novel approaches to cardioprotection
    Program: Inter-academic agreement
    Duration: 1. 1. 2015 – 31. 12. 2017

National

Current
  • Novel antidiabetic/antiobesty drugs as innovative pharmacotherapeutic tools for cardioprotection in experimental model of type 2 diabetes
    Program: VEGA
    Duration: 1. 1. 2024 – 31. 12. 2027
  • New aspects of cardioprotection by natural antioxidants: role of ageing and lifestyle-related comorbidities
    Program: SRDA
    Duration: 1. 7. 2022 – 30. 6. 2026
  • Necroptotic and pleiotropic effects of RIP3 kinase acting as a convergent point in cardiac cell loss: understanding the basic mechanisms in the ischemic heart with or without metabolic stress as a tool for designing therapeutic approaches.
    Program: SRDA
    Duration: 1. 7. 2021 – 30. 6. 2025
Finished
  • The role of miRNAs in the onset and progression of cardiovascular diseases - new approach to the protection of the heart in situations of increased production of reactive oxygen species
    Program: SRDA
    Duration: 1. 7. 2020 – 30. 6. 2024
  • Investigation of endotoxin effects on mechanosensoric complex in the heart of normotensive rats.
    Program: VEGA
    Duration: 1. 12. 2020 – 31. 12. 2022
  • Dynamics of myocardial damage: a role of necroptotic cell death and survival of cardiomyocytes.
    Program: SRDA
    Duration: 1. 7. 2016 – 30. 6. 2020
  • Hypoxia in the prevention of heart failure in rats and its influence in various stages of heart failure: Characteristics of functional, structural and molecular changes.
    Program: VEGA
    Duration: 1. 1. 2017 – 31. 12. 2019
Employees